We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Medica 2024 Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Soy Component Vital in the Fight Against Colon Cancer

By LabMedica International staff writers
Posted on 21 Dec 2009
A study identifies a new class of therapeutic agents found naturally in soy (Glycine max) that can prevent and possibly treat colon cancer, the third most deadly form of cancer. Sphingadienes (SDs) are natural lipid molecules found in soy that research reveals may be the key to fighting colon cancer.

The study led by Julie Saba, M.D., Ph.D., senior scientist and director of the Cancer Center at Children's Hospital Oakland Research Institute (CHORI; CA, USA), was published in the December 15, 2009, issue of the journal Cancer Research. Soy has long been seen as protective against colon cancer, but Dr. Saba's team made the discovery that SDs naturally found in soy may underlie the benefits of soy products.

Dr. Saba and her colleagues first identified SDs in the fruit fly, an organism that is sometimes used to study the genetics of human diseases. Additional study indicated that elevated SDs actually induced the death of mutant cells in the fly, revealing SDs to be cytotoxic compounds (toxic to cells). Preventative colon-cancer strategies frequently focus on cell death--a normal process the body uses to remove unhealthy or mutant cells, like cancer cells. Combining this discovery with the finding that soy is a rich source of SDs, researchers made an innovative connection.

"It's very exciting,” said Dr. Saba. "First, we are encouraged to find a natural molecule that could be consumed through soy products as a strategy to help prevent colon cancer. Second, this information is important because we can build on our understanding of the structure and metabolism of SDs in terms of developing new drugs to treat people who already have colon cancer. Uncovering how SDs exert their effects also helps us to find the most likely combinations of drugs that may work synergistically to eliminate cancer cells and mutant cells that could give rise to cancer.”

Future research is needed to identify the best way to deliver SDs and to confirm the overall toxicity when the compounds are used for extended periods and in combination with other agents. Dr. Saba, who has already received two grants to continue her research, also hopes to determine if SDs are effective in protection against other cancers.

Dr. Saba also acknowledges that future research is needed to determine if there are other components of soy that are beneficial in fighting colon cancer. In the meantime, Dr. Saba concluded, "I would be comfortable recommending soy products as a change in the diet that could protect against cancer. The more that soy is studied, the more of these protective agents are found, so it's a very healthy diet choice.”

Related Links:
Cancer Center at Children's Hospital Oakland Research Institute



New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Leishmania Test
Leishmania Real Time PCR Kit
New
Serum Toxicology Benzodiazepine Assay
DRI Serum Toxicology Benzodiazepine Assay

Latest BioResearch News

Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns

Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma

New Method Simplifies Preparation of Tumor Genomic DNA Libraries